Drug Trial Radar · NCT05018585
A Phase III Study to Investigate if the Study Drug Diamyd Can Preserve Insulin Production and Improve Glycemic Control in Patients Newly Diagnosed With Type 1 Diabetes
Last checked: Nov 20, 2026Latest source record: Aug 26, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Terminated
Enrollment
321
Actual
Start
May 19, 2022
Primary completion
Jun 24, 2026
Study completion Jun 24, 2026
Sponsor
- Lead sponsor
- Diamyd Medical ABIndustry
- Sponsor type
- Industry
- First posted
- Aug 24, 2021
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 12 years, up to 28 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The objective of DIAGNODE-3 is to evaluate the efficacy and safety of three intranodal injections of 4 μg of Diamyd also known as retogatein compared to placebo, along with oral Vitamin D supplementation, to preserve endogenous beta cell function and influence glycemic parameters in adolescent and adults recently diagnosed with T1D carrying the HLA DR3-DQ2 haplotype.
Conditions
- Type 1 Diabetes Mellitus
Interventions
Recombinant human glutamic acid decarboxylase (rhGAD65) formulated in Alhydrogel®Biological
Recombinant human glutamic acid decarboxylase (rhGAD65) formulated in Alhydrogel®
Colecalciferol 2000 IUDietary supplement
Colecalciferol (vitamin D3) 2000 IU (equivalent to 50 microgram vitamin D3).
PlaceboBiological
Placebo for Diamyd, Alhydrogel® only
Primary outcomes
What the sponsor says the trial is designed to measure.
- Beta cell functionTime frame: Baseline to 15 months
- Glycemic controlTime frame: Baseline to 15 months
Locations
60 sites in 9 countries. Site status is shown where the registry gives one.
Mary and Dick Allen Diabetes Center at Hoag Hospital
Newport Beach, California
Stanford University School of Medicine Center for Academic Medicine
Palo Alto, California
UCSD/ Rady Children's Hospital
San Diego, California
University of Colorado Anschutz Medical Campus, Barbara Davis Center for Childhood Diabetes
Aurora, Colorado
Diabetes Research Institute (DRI)-University of Miami Leonard M. Miller School of Medicine (UMMSM)
Miami, Florida
Rocky Mountain Diabetes and Osteoporosis Center
Idaho Falls, Idaho
University of Iowa Hospital and Clinics
Iowa City, Iowa
Johns Hopkins University
Baltimore, Maryland
The Joslin Center
Boston, Massachusetts
Washington University Diabetes Center at Barnes Jewish Hospital
St Louis, Missouri
Hassenfeld Children's Hospital at NYU Langone Health, Pediatric Diabetes Center
New York, New York
Amarillo Medical Specialists
Amarillo, Texas
Diabetes & Glandular Disease Clinic
San Antonio, Texas
Nemocnice Jihlava, příspěvková organizace
Jihlava, Czechia
Institut klinické a experimentální medicíny
Prague, Czechia
Fakultní nemocnice v Motole
Prague, Czechia
Krajská zdravotní, a.s. - Masarykova nemocnice v Ústí nad Labem, o.z.
Ústí nad Labem, Czechia
Liina Viitas OÜ
Pärnu, Estonia
North-Estonian Regional Hospital
Tallinn, Estonia
Tartu University Hospital
Tartu, Estonia
Tartu University Hospital, Children's Clinic
Tartu, Estonia
Diabetespraxis Dr. Braun
Berlin, Germany
Diabetologische Schwerpunktpraxis Dres. Klaus
Dortmund, Germany
DZDM - Diabeteszentrum Duisburg Mitte
Duisburg, Germany
Justus-Liebig-Universität Gießen
Giessen, Germany
Óbudai Egészségügyi Centrum
Budapest, Hungary
Heim Pál Országos Gyermekgyógyászati Intézet, Diabetológia
Budapest, Hungary
Észak-Budai Szent János Centrumkórház, Kútvölgyi Kórház, Belgyógyászat
Budapest, Hungary
Szabolcs-Szatmár-Bereg Megyei Kórházak és Egyetemi, Oktatókórház, Jósa András Oktatókórház, Gyermekosztály
Nyíregyháza, Hungary
Markusovszky Egyetemi Oktatókórház, Diabetológiai Szakrendelés
Szombathely, Hungary
CTU Vasculaire Geneeskunde, Locatie Academic Medical Center (AMC)
Amsterdam, Netherlands
Albert Schweitzer Ziekenhuis
Dordrecht, Netherlands
Bethesda Diabetes Research Center te Hoogeveen
Hoogeveen, Netherlands
Dept. of Nephrology / Dept. of Endocrinology, Leiden University Medical Center (LUMC)
Leiden, Netherlands
Vivendia
Nijmegen, Netherlands
Diabeter Nederland te Rotterdam
Rotterdam, Netherlands
Uniwersytecki Dziecięcy Szpital Kliniczny im. L. Zamenhofa w Białymstoku, Klinika Pediatrii, Endokrynologii, Diabetologii z Pododdziałem Kardiologii
Bialystok, Poland
Uniwersyteckie Centrum Kliniczne, Klinika Pediatrii, Diabetologii i Endokrynologii
Gdansk, Poland
SP ZOZ Szpital Uniwersytecki w Krakowie, Oddział Kliniczny Chorób Metabolicznych i Diabetologii
Krakow, Poland
NZOZ Przychodnia Specjalistyczna Medica
Lublin, Poland
Showing 40 of 60 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.